Endogenous Retroviruses as Etiological Agents in Systemic Lupus Erythematosus

Infection and Autoimmunity, 2nd edition

Volumn , Issue , 2004, Pages 271-288

  Adelman, Miranda K ^a   Yocum, David E ^a   Marchalonis, John J ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882832000     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-044451271-0.50023-5     Document Type: Chapter

References (145)

1. Mongey A, Hes EV The role of environment in systemic lupus erythematosus and associated disorders. Dubois' Lupus Erythematosus 1997, 31-47. Williams and Wilkins, Baltimore. D.J. Wallance, B.H. Hahn (Eds.).
2. Yung RL, Richardson BC Drug-induced lupus. Rheum Dis Clin North Am 1994, 20(1):61-86.
3. Rothfield N Clinical features of systemic lupus erythematosus. Textbook of Rheumatology 1985, 1070-1097. Saunders, Philadelphia. Lelley, Harris, Ruddy, Sledge (Eds.).
4. Kelly JA, Moser KL, Harley JB The genetics of systemic lupus erythematosus: putting the pieces together. Genes Immun 2002, 3(Suppl 1):S71-S85.
5. Deapen D, Escalante A, Weinrib L, Horwitz D, Bachman B, Roy-Burman P, Walker A, Mack TM A revised estimate of twin concordance in systemic lupus erythematosus. Arthritis Rheum 1992, 35(3):311-318.
6. Vyse TJ, Kotzin BL Genetic susceptibility to systemic lupus erythematosus. Annu Rev Immunol 1998, 16:261-292.
7. Vyse TJ, Todd JA Genetic analysis of autoimmune disease. Cell 1996, 85(3):311-318.
8. Tsao BP, Cantor RM, Kalunian KC, Chen CJ, Badsha H, Singh R, Wallace DJ, Kitridou RC, Chen SL, Shen N, Song YW, Isenberg DA, Yu CL, Hahn BH, Rotter JI Evidence for linkage of a candidate chromosome 1 region to human systemic lupus erythematosus. J Clin Invest 1997, 99(4):725-731.
9. Moser KL, Neas BR, Salmon JE, Yu H, Gray-McGuire C, Asundi N, Bruner GR, Fox J, Kelly J, Henshall S, Bacino D, Dietz M, Hogue R, Koelsch G, Nightingale L, Shaver T, Abdou NI, Albert DA, Carson C, Petri M, Treadwell EL, James JA, Harley JB Genome scan of human systemic lupus erythematosus: evidence for linkage on chromosome 1q in African-American pedigrees. Proc Natl Acad Sci USA 1998, 95:14869-14874.
10. Moser KL, Gray-McGuire C, Kelly J, Asundi N, Yu H, Bruner GR, Mange M, Hogue R, Neas BR, Harley JB Confirmation of genetic linkage between human systemic lupus erythematosus and chromosome 1q41. Arthritis Rheum 1999, 42(9):1902-1907.
11. Yoshiki T, Mellors RC, Strand M, August JT The viral envelope glycoprotein of murine leukemia virus and the pathogenesis of immune complex glomerulone-phritis of New Zealand mice. J Exp Med 1974, 140(4):1011-1027.
12. Lander ES Initial sequencing and analysis of the human genome. Nature 2001, 409(6822):860-921.
13. Nelson PN, Carnegie PR, Martin J, Davari Ejtehadi H, Hooley P, Roden D, Rowland-Jones S, Warren P, Astley J, Murray PG Demystified. Human endogenous retroviruses. Mol Pathol 2003, 56(1):11-18.
14. Kazazian HH Genetics. L1 retrotransposons shape the mammalian genome. Science 2000, 289(5482):1152-1153.
15. Perl A Role of endogenous retroviruses in autoimmune diseases. Rheum Dis Clin North Am 2003, 29(1):123-143.
16. Perl A Role of endogenous retroviruses in autoimmune diseases. Rheum Dis Clin North Am 2003, 29(1):vii.
17. Wilkinson DA, Mager DL, Leong J-AC Endogenous human retroviruses. The Retroviridae 1994, 465-535. Plenum Press, New York. J.A. Levy (Ed.).
18. Lower R, Lower J, Kurth R The viruses in all of us: characteristics and biological significance of human endogenous retrovirus sequences. Proc Natl Acad Sci USA 1996, 93:5177-5184.
19. Perl A, Colombo E, Dai H, Agarwal R, Mark KA, Banki K, Poiesz BJ, Phillips PE, Hoch SO, Reveille JD, Arnett FC Antibody reactivity to the HRES-1 endogenous retroviral element identifies a subset of patients with systemic lupus erythematosus and overlap syndromes. Correlation with antinuclear antibodies and HLA class II alleles. Arthritis Rheum 1995, 38(11):1660-1671.
20. Sekigawa I, Okada M, Ogasawara H, Naito T, Kaneko H, Hishikawa T, Iida N, Hashimoto H Lessons from similarities between SLE and HIV infection. J Infect 2002, 44(2):67-72.
21. Schluter SF, Marchalonis JJ Cloning of shark RAG2 and characterization of the RAG1/RAG2 gene locus. Faseb J 2003, 17(3):470-472.
22. Martin MA, Bryan T, Rasheed S, Khan AS Identification and cloning of endogenous retroviral sequences present in human DNA. Proc Natl Acad Sci USA 1981, 78:4892-4896.
23. Andersson ML, Lindeskog M, Medstrand P, Westley B, May F, Blomberg J Diversity of human endogenous retrovirus class II-like sequences. J Gen Virol 1999, 80(Pt 1):255-260.
24. Franklin GC, Chretien S, Hanson IM, Rochefort H, May FE, Westley BR Expression of human sequences related to those of mouse mammary tumor virus. J Virol 1988, 62(4):1203-1210.
25. Medstrand P, Blomberg J Characterization of novel reverse transcriptase encoding human endogenous retroviral sequences similar to type A and type B retroviruses: differential transcription in normal human tissues. J Virol 1993, 67(11):6778-6787.
26. Coffin JM Genetic diversity and evolution of retroviruses. Curr Top Microbiol Immunol 1992, 176:143-164.
27. Tonjes RR, Lower R, Boller K, Denner J, Hasenmaier B, Kirsch H, Konig H, Korbmacher C, Limbach C, Lugert R, Phelps RC, Scherer J, Thelen K, Lower J, Kurth R HERV-K: the biologically most active human endogenous retrovirus family. J Acquir Immune Defic Syndr Hum Retrovirol 1996, 13(Suppl 1):S261-S267.
28. Lower R, Boller K, Hasenmaier B, Korbmacher C, Muller-Lantzsch N, Lower J, Kurth R Identification of human endogenous retroviruses with complex mRNA expression and particle formation. Proc Natl Acad Sci USA 1993, 90:4480-4484.
29. Adelman MK, Marchalonis JJ Endogenous retroviruses in systemic lupus erythematosus: candidate lupus viruses. Clin Immunol 2002, 102(2):107-116.
30. Magistrelli C, Samoilova E, Agarwal RK, Banki K, Ferrante P, Vladutiu A, Phillips PE, Perl A Polymorphic genotypes of the HRES-1 human endogenous retrovirus locus correlate with systemic lupus erythematosus and autoreactivity. Immunogenetics 1999, 49(10):829-834.
31. Rasmussen HB, Kelly MA, Francis DA, Clausen J Association between the endogenous retrovirus HRES-1 and multiple sclerosis in the United Kingdom-evidence of genetically different disease substets?. Dis Markers 2000, 16(3-4):101-104.
32. Banki K, Maceda J, Hurley E, Ablonczy E, Mattson DH, Szegedy L, Hung C, Perl A Human T-cell lymphotropic virus (HTLV)-related endogenous sequence, HRES-1, encodes a 28-kDA protein: a possible autoantigen, for HTLV-I gag-reactive autoantibodies. Proc Natl Acad Sci USA 1992, 89:1939-1943.
33. Chu JL, Drappa J, Parnassa A, Elkon KB The defect in Fas mRNA expression in MRL/lpr mice is associated with insertion of the retrotransposon, ETn. J Exp Med 1993, 178(2):723-730.
34. Wu J, Zhou T, He J, Mountz JD Autoimmune disease in mice due to integration of an endogenous retrovirus in an apoptosis gene. J Exp Med 1993, 178(2):461-468.
35. Vyse TJ, Kotzin BL Genetic basis of systemic lupus erythematosus. Curr Opin Immunol 1996, 8(6):843-851.
36. Sekigawa I, Matsushita M, Lee S, Maeda N, Ogasawara H, Kaneko H, Iida N, Hashimoto H A possible pathogenic role of CD8+ T cells and their derived cytokine, IL-16, in SLE. Autoimmunity 2000, 33(1):37-44.
37. Lee S, Kaneko H, Sekigawa I, Tokano Y, Takasaki Y, Hashimoto H Circulating interleukin-16 in systemic lupus erythematosus. Br J Rheumatol 1998, 37(12):1334-1337.
38. Bisset LR, Rothen M, Joller-Jemelka HI, Dubs RW, Grob PJ, Opravil M Change in circulating levels of the chemokines macrophage inflammatory proteins 1 alpha and 11 beta, RANTES, monocyte chemotactic protein-1 and interleukin-16 following treatment of severely immunodeficient HIV-infected individuals with indinavir. Aids 1997, 11(4):485-491.
39. Center DM, Kornfeld H, Cruikshank WW Interleukin-16. Int J Biochem Cell Biol 1997, 29(11):1231-1234.
40. Fox RA, Isenberg DA Human immunodeficiency virus infection in systemic lupus erythematosus. Arthritis Rheum 1997, 40(6):1168-1172.
41. Diri E, Lipsky PE, Bergreen RE Emergence of systemic lupus erythematosus after initiation of highly active antiretroviral therapy for human immunodeficiency virus infection. J Rheumatol 2000, 27(11):2711-2714.
42. Barthel HR, Wallace DJ False-positive human immunodeficiency virus testing in patients with lupus erythematosus. Semin Arthritis Rheum 1993, 23(1):1-7.
43. Alonso CM, Lozada CJ Effects of IV cyclophosphamide on HIV viral replication in a patient with systemic lupus erythematosus. Clin Exp Rheumatol 2000, 18(4):510-512.
44. Center DM, Kornfeld H, Cruikshank WW Interleukin 16 and its function as a CD4 ligand. Immunol Today 1996, 17(10):476-481.
45. Deas JE, Liu LG, Thompson JJ, Sander DM, Soble SS, Garry RF, Gallaher WR Reactivity of sera from systemic lupus erythematosus and Sjögren's syndrome patients with peptides derived from human immuno-deficiency virus p24 capsid antigen. Clin Diagn Lab Immunol 1998, 5(2):181-185.
46. Talal N, Garry RF, Schur PH, Alexander S, Dauphinee MJ, Livas IH, Ballester A, Takei M, Dang H A conserved idiotype and antibodies to retroviral proteins in systemic lupus erythematosus. J Clin Invest 1990, 85(6):1866-1871.
47. Phillips PE, Johnston SL, Runge LA, Moore JL, Poiesz BJ High IgM antibody to human T-lymphotropic virus type I in systemic lupus erythematosus. J Clin Immunol 1986, 6(3):234-241.
48. Blomberg J, Nived O, Pipkorn R, Bengtsson A, Erlinge D, Sturfelt G Increased antiretroviral antibody reactivity in sera from a defined population of patients with systemic lupus erythematosus. Correlation with auto-antibodies and clinical manifestations. Arthritis Rheum 1994, 37(1):57-66.
49. Griffiths DJ, Cooke SP, Herve C, Rigby SP, Mallon E, Hajeer A, Lock M, Emery V, Taylor P, Pantelidis P, Bunker CB, du Bois R, Weiss RA, Venables PJ Detection of human retrovirus 5 in patients with arthritis and systemic lupus erythematosus. Arthritis Rheum 1999, 42(3):448-454.
50. Garry RF New evidence for involvement of retroviruses in Sjögren's syndrome and other autoimmune diseases. Arthritis Rheum 1994, 37(4):465-469.
51. Talal N, Dauphinee MJ, Dang H, Alexander SS, Hart DJ, Garry RF Detection of serum antibodies to retroviral proteins in patients with primary Sjögren's syndrome (autoimmune exocrinopathy). Arthritis Rheum 1990, 33(6):774-781.
52. Nelson PN, Lever AM, Bruckner FE, Isenberg DA, Kessaris N, Hay FC Polymerase chain reaction fails to incriminate exogenous retroviruses HTLV-I and HIV-1 in rheumatological diseases although a minority of sera cross react with retroviral antigens. Ann Rheum Dis 1994, 53(11):749-754.
53. Lefranc D, Dubucquoi S, Almeras L, De Seze J, Tourvieille B, Dussart P, Aubert JP, Vermersch P, Prin L Molecular analysis of endogenous retrovirus HRES-1: identification of frameshift mutations in region encod- ing putative 28-kDa autoantigen. Biochem Biophys Res Commun 2001, 283(2):437-444.
54. Query CC, Keene JD A human autoimmune protein associated with U1 RNA contains a region of homology that is cross-reactive with retroviral p30gag antigen. Cell 1987, 51(2):211-220.
55. Ogasawara H, Kaneko H, Hishikawa T, Sekigawa I, Takasaki Y, Hashimoto H, Hirose S, Kaneko Y, Maruyama N Molecular mimicry between human endogenous retrovirus clone 4-1 and HLA class I antigen with reference to the pathogenesis of systemic lupus erythematosus. Rheumatology (Oxf) 1999, 38(11):1163-1164.
56. Ogasawara H, Hishikawa T, Sekigawa I, Hashimoto H, Yamamoto N, Maruyama N Sequence analysis of human endogenous retrovirus clone 4-1 in systemic lupus erythematosus. Autoimmunity 2000, 33(1):15-21.
57. Garry RF, Fermin CD, Hart DJ, Alexander SS, Donehower LA, Luo-Zhang H Detection of a human intracisternal A-type retroviral particle antigenically related to HIV. Science 1990, 250(4984):1127-1129.
58. Yamano S, Renard JN, Mizuno F, Narita Y, Uchida Y, Higashiyama H, Sakurai H, Saito I Retrovirus in salivary glands from patients with Sjögren's syndrome. J Clin Pathol 1997, 50(3):223-230.
59. Stransky G, Vernon J, Aicher WK, Moreland LW, Gay RE, Gay S Virus-like particles in synovial fluids from patients with rheumatoid arthritis. Br J Rheumatol 1993, 32(12):1044-1048.
60. Nakagawa K, Brusic V, McColl G, Harrison LC Direct evidence for the expression of multiple endogenous retroviruses in the synovial compartment in rheumatoid arthritis. Arthritis Rheum 1997, 40(4):627-638.
61. Ziegler B, Gay RE, Huang GQ, Fassbender HG, Gay S Immunohistochemical localization of HTLV-I p19- and p24-related antigens in synovial joints of patients with rheumatoid arthritis. Am J Pathol 1989, 135(1):1-5.
62. Shih A, Misra R, Rush MG Detection of multiple, novel reverse transcriptase coding sequences in human nucleic acids: relation to primate retroviruses. J Virol 1989, 63(1):64-75.
63. Perron H, Lalande B, Gratacap B, Laurent A, Genoulaz O, Geny C, Mallaret M, Schuller E, Stoebner P, Seigneurin JM Isolation of retrovirus from patients with multiple sclerosis. Lancet 1991, 337(8745):862-863.
64. Lan XY, Zeng Y, Zhang D, Hong ML, Wang DX, Zhang YL, Feng ZJ, Tang MH, Feng BZ Establishment of a human malignant T lymphoma cell line carrying retrovirus-like particles with RT activity. Biomed Environ Sci 1994, 7(1):1-12.
65. Haahr S, Sommerlund M, Moller-Larsen A, Nielsen R, Hansen HJ Just another dubious virus in cells from a patient with multiple sclerosis?. Lancet 1991, 337(8745):863-864.
66. Herrman M, Hagenhofer M, Kalden JR Retroviruses and systemic lupus erythematosus. Immunol Rev 1996, 152:145-156.
67. Denman A Induction of interferon by lentiviruses. Immunol Today 1986, 7:201-203.
68. Izui S, McConahey PJ, Clark JP, Hang LM, Hara I, Dixon FJ Retroviral gp70 immune complexes in NZB x NZW F2 mice with murine lupus nephritis. J Exp Med 1981, 154(2):517-528.
69. Tucker RM, Vyse TJ, Rozzo S, Roark CL, Izui S, Kotzin BL Genetic control of glycoprotein 70 autoantigen production and its influence on immune complex levels and nephritis in murine lupus. J Immunol 2000, 165(3):1665-1672.
70. Theofilopoulos AN, Dixon FJ Murine models of systemic lupus erythematosus. Adv Immunol 1985, 37:269-390.
71. Alexander JJ, Saxena AK, Bao L, Jacob A, Haas M, Quigg RJ Prominent renal expression of a murine leukemia retrovirus in experimental systemic lupus erythematosus. J Am Soc Nephrol 2002, 13(12):2869-2877.
72. Andrews BS, Eisenberg RA, Theofilopoulos AN, Izui S, Wilson CB, McConahey PJ, Murphy ED, Roths JB, Dixon FJ Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains. J Exp Med 1978, 148(5):1198-1215.
73. Kotzin BL Susceptibility loci for lupus: a guiding light from murine models?. J Clin Invest 1997, 99(4):557-558.
74. Tsao BP, Cantor RM, Kalunian KC, Wallace DJ, Hahn BH, Rotter JI The genetic basis of systemic lupus erythematosus. Proc Assoc Am Physicians 1998, 110:113-117.
75. Gaffney PM, Ortmann WA, Selby SA, Shark KB, Ockenden TC, Rohlf KE, Walgrave NL, Boyum WP, Malmgren ML, Miller ME, Kearns GM, Messner RP, King RA, Rich SS, Behrens TW Genome screening in human systemic lupus erythematosus: results from a second Minnesota cohort and combined analyses of 187 sib-pair families. Am J Hum Genet 2000, 66(2):547-556.
76. Marrack P, Winslow GM, Choi Y, Scherer M, Pullen A, White J, Kappler JW The bacterial and mouse mammary tumor virus superantigens; two different families of proteins with the same functions. Immunol Rev 1993, 131:79-92.
77. Perron H, Jouvin-Marche E, Michel M, Ounanian-Paraz A, Camelo S, Dumon A, Jolivet-Reynaud C, Marcel F, Souillet Y, Borel E, Gebuhrer L, Santoro L, Marcel S, Seigneurin JM, Marche PN, Lafon M Multiple sclerosis retrovirus particles and recombinant envelope trigger an abnormal immune response in vitro, by inducing polyclonal Vbeta 16 T-lymphocyte activation. Virology 2001, 287(2):321-332.
78. Conrad B, Weidmann E, Trucco G, Rudert WA, Behboo R, Ricordi C, Rodriquez-Rilo H, Finegold D, Trucco M Evidence for superantigen involvement in insulin-dependent diabetes mellitus aetiology. Nature 1994, 371(6495):351-355.
79. Conrad B, Weissmahr RN, Boni J, Arcari R, Schupbach J, Mach B A human endogenous retroviral superantigen as candidate autoimmune gene in type I diabetes. Cell 1997, 90(2):303-313.
80. Stauffer Y, Marguerat S, Meylan F, Ucla C, Sutkowski N, Huber B, Pelet T, Conrad B Interferon-alpha-induced endogenous superantigen. a model linking environment and autoimmunity. Immunity 2001, 15(4):591-601.
81. Sutkowski N, Conrad B, Thorley-Lawson DA, Huber BT Epstein-Barr virus transactivates the human endogenous retrovirus HERV-K18 that encodes a superantigen. Immunity 2001, 15(4):579-589.
82. Lapatschek M, Durr S, Lower R, Magin C, Wagner H, Miethke T Functional analysis of the env open reading frame in human endogenous retrovirus IDDMK(1,2)22 encoding superantigen activity. J Virol 2000, 74(14):6386-6393.
83. Jaeckel E, Heringlake S, Berger D, Brabant G, Hunsmann G, Manns MP No evidence for association between IDDMK(1,2)22, a novel isolated retrovirus, and IDDM. Diabetes 1999, 48(1):209-214.
84. Lower R, Tonjes RR, Boller K, Denner J, Kaiser B, Phelps RC, Lower J, Kurth R, Badenhoop K, Donner H, Usadel KH, Miethke T, Lapatschek M, Wagner H Development of insulin-dependent diabetes mellitus does not depend on specific expression of the human endogenous retrovirus HERV-K. Cell 1998, 95(1):11-14. discussion 16.
85. Murphy VJ, Harrison LC, Rudert WA, Luppi P, Trucco M, Fierabracci A, Biro PA, Bottazzo GF Retroviral superantigens and type 1 diabetes mellitus. Cell 1998, 95(1):9-11. discussion 16.
86. Badenhoop K, Donner H, Neuman J, Herwig J, Kurth R, Usadel KH, Tonjes RR IDDM patients neither show humoral reactivities against endogenous retroviral envelope protein nor do they differ in retroviral mRNA expression from healthy relatives or normal individuals. Diabetes 1999, 48(1):215-218.
87. Lan MS, Mason A, Coutant R, Chen QY, Vargas A, Rao J, Gomez R, Chalew S, Garry R, Maclaren NK HERV-K10s and immune-mediated (type 1) diabetes. Cell 1998, 95(1):14-16. discussion 16.
88. Muir A, Ruan QG, Marron MP, She JX The IDDMK(1,2)22 retrovirus is not detectable in either mRNA or genomic DNA from patients with type 1 diabetes. Diabetes 1999, 48(1):219-222.
89. Hasuike S, Miura K, Miyoshi O, Miyamoto T, Niikawa N, Jinno Y, Ishikawa M Isolation and localization of an IDDMK1,2-22-related human endogenous retroviral gene, and identification of a CA repeat marker at its locus. J Hum Genet 1999, 44(5):343-347.
90. Mein CA, Esposito L, Dunn MG, Johnson GC, Timms AE, Goy JV, Smith AN, Sebag-Montefiore L, Merriman ME, Wilson AJ, Pritchard LE, Cucca F, Barnett AH, Bain SC, Todd JA A search for type 1 diabetes susceptibility genes in families from the United Kingdom. Nat Genet 1998, 19(3):297-300.
91. Luppi P, Zanone MM, Hyoty H, Rudert WA, Haluszczak C, Alexander AM, Bertera S, Becker D, Trucco M Restricted TCR V beta gene expression and enterovirus infection in type I diabetes. Diabetologia 2000, 43:1484-1497.
92. Perron H, Garson JA, Bedin F, Beseme F, Paranhos-Baccala G, Komurian-Pradel F, Mallet F, Tuke PW, Voisset C, Blond JL, Lalande B, Seigneurin JM, Mandrand B Molecular identification of a novel retrovirus repeatedly isolated from patients with multiple sclerosis. The Collaborative Research Group on Multiple Sclerosis. Proc Natl Acad Sci USA 1997, 94:7583-7588.
93. Blond JL, Beseme F, Duret L, Bouton O, Bedin F, Perron H, Mandrand B, Mallet F Molecular characterization and placental expression of HERV-W, a new human endogenous retrovirus family. J Virol 1999, 73(2):1175-1185.
94. Blatt NB, Glick GD Anti-DNA autoantibodies and systemic lupus erythematosus. Pharmacol Ther 1999, 83(2):125-139.
95. Andersson G, Svensson AC, Setterblad N, Rask L Retroelements in the human MHC class II region. Trends Genet 1998, 14(3):109-114.
96. Kulski JK, Gaudieri S, Inoko H, Dawkins RL Comparison between two human endogenous retrovirus (HERV)-rich regions within the major histocompatibility complex. J Mol Evol 1999, 48(6):675-683.
97. Kulski JK, Dawkins RL The P5 multicopy gene family in the MHC is related in sequence to human endogenous retroviruses HERV-L and HERV-16. Immunogenetics 1999, 49(5):404-412.
98. Cameron PU, Mallal SA, French MAH Central MHC genes between HLA-B and complement C4 confer risk for HIV-1 disease progression. HLA 1991 1992, 544-547. Oxford Univ Press, New York. K. Tsuji, M. Aizawa, T. Sasazuki (Eds.).
99. Leelayuwat C, Zhang WJ, Abraham LJ, Townend DC, Gaudieri S, Dawkins RL Differences in the central major histocompatibility complex between humans and chimpanzees. Implications for development of autoimmunity and acquired immune deficiency syndrome. Hum Immunol 1993, 38(1):30-41.
100. Heeney JL, van Els C, de Vries P, ten Haaft P, Otting N, Koornstra W, Boes J, Dubbes R, Niphuis H, Dings M, Cranage M, Norley S, Jonker S, Bontrop RE, Osterhaus A Major histocompatibility complex class I-associated vaccine protection from simian immunodeficiency virus-infected peripheral blood cells. J Exp Med 1994, 180(2):769-774.
101. Strazzullo M, Majello B, Lania L, La Mantia G Mutational analysis of the human endogenous ERV9 proviruses promoter region. Virology 1994, 200(2):686-695.
102. Ratnoff WD Inherited deficiences of complement in rheumatic diseases. Rheum Dis Clin North Am 1996, 22(1):75-94.
103. Grant SF, Kristjansdottir H, Steinsson K, Blondal T, Yuryev A, Stefansson K, Gulcher JR Long PCR detection of the C4A null allele in B8-C4AQ0-C4B1-DR3. J Immunol Methods 2000, 244(1-2):41-47.
104. Fielder AH, Walport MJ, Batchelor JR, Rynes RI, Black CM, Dodi IA, Hughes GR Family study of the major histocompatibility complex in patients with systemic lupus erythematosus: importance of null alleles of C4A and C4B in determining disease susceptibility. Br Med J (Clin Res Ed) 1983, 286(6363):425-428.
105. Arnett FC Genetic aspects of human lupus. Clin Immunol Immunopathol 1992, 63(1):4-6.
106. Reveille JD, Arnett FC, Wilson RW, Bias WB, McLean RH Null alleles of the fourth component of complement and HLA haplotypes in familial systemic lupus erythematosus. Immunogenetics 1985, 21(4):299-311.
107. Dangel AW, Mendoza AR, Baker BJ, Daniel CM, Carroll MC, Wu LC, Yu CY The dichotomous size variation of human complement C4 genes is mediated by a novel family of endogenous retroviruses, which also establishes species-specific genomic patterns among Old World primates. Immunogenetics 1994, 40(6):425-436.
108. Zhu ZB, Hsieh SL, Bentley DR, Campbell RD, Volanakis JE A variable number of tandem repeats locus within the human complement C2 gene is associated with a retroposon derived from a human endogenous retrovirus. J Exp Med 1992, 175(6):1783-1787.
109. Lower R, Tonjes RR, Korbmacher C, Kurth R, Lower J Identification of a Rev-related protein by analysis of spliced transcripts of the human endogenous retroviruses HTDV/HERV-K. J Virol 1995, 69(1):141-149.
110. Horwitz MS, Boyce-Jacino MT, Faras AJ Novel human endogenous sequences related to human immunodeficiency virus type 1. J Virol 1992, 66(4):2170-2179.
111. Oostendorp RA, Schaaper WM, Post J, Von Blomberg BM, Meloen RH, Scheper RJ Suppression of lymphocyte proliferation by a retroviral p15E-derived hexapeptide. Eur J Immunol 1992, 22(6):1505-1511.
112. Ogasawara M, Cianciolo GJ, Synderman R, Mitani M, Good RA, Day NK Human IFN-gamma production is inhibited by a synthetic peptide homologous to retroviral envelope protein. J Immunol 1988, 141(2):614-619.
113. Ogasawara M, Haraguchi S, Cianciolo GJ, Mitani M, Good RA, Day NK Inhibition of murine cytotoxic T lymphocyte activity by a synthetic retroviral peptide and abrogation of this activity by IL. J Immunol 1990, 145(2):456-462.
114. Haraguchi S, Liu WT, Cianciolo GJ, Good RA, Day NK Suppression of human interferon-gamma production by a 17 amino acid peptide homologous to the transmembrane envelope protein of retroviruses: evidence for a primary role played by monocytes. Cell Immunol 1992, 141(2):388-397.
115. Nelson M, Nelson DS, Cianciolo GJ, Snyderman R Effects of CKS-17, a synthetic retroviral envelope peptide, on cell-mediated immunity in vivo: immunosuppression, immunogenicity, and relation to immunosuppressive tumor products. Cancer Immunol Immunother 1989, 30(2):113-118.
116. Haraguchi S, Good RA, James-Yarish M, Cianciolo GJ, Day NK Differential modulation of Th1- and Th2-related cytokine mRNA expression by a synthetic peptide homologous to a conserved domain within retroviral envelope protein. Proc Natl Acad Sci USA 1995, 92:3611-3615.
117. Modlin RL, Nutman TB Type 2 cytokines and negative immune regulation in human infections. Curr Opin Immunol 1993, 5(4):511-517.
118. Sher A, Gazzinelli RT, Oswald IP, Clerici M, Kullberg M, Pearce EJ, Berzofsky JA, Mosmann TR, James SL, Morse HC Role of T-cell derived cytokines in the downregulation of immune responses in parasitic and retroviral infection. Immunol Rev 1992, 127:183-204.
119. D'Andrea A, Aste-Amezaga M, Valiante NM, Ma X, Kubin M, Trinchieri G Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J Exp Med 1993, 178(3):1041-1048.
120. Clerici M, Lucey DR, Berzofsky JA, Pinto LA, Wynn TA, Blatt SP, Dolan MJ, Hendrix CW, Wolf SF, Shearer GM Restoration of HIV-specific cell-mediated immune responses by interleukin-12 in vitro. Science 1993, 262(5140):1721-1724.
121. Chehimi J, Trinchieri G Interleukin-12: a bridge between innate resistance and adaptive immunity with a role in infection and acquired immunodeficiency. J Clin Immunol 1994, 14(3):149-161.
122. Cianciolo GJ, Bogerd H, Snyderman R Human retrovirus-related synthetic peptides inhibit T lymphocyte proliferation. Immunol Lett 1988, 19(1):7-13.
123. Scheeren RA, Oostendorp RA, van der Baan S, Keehnen RM, Scheper RJ, Meijer CJ Distribution of retroviral p15E-related proteins in neoplastic and non-neoplastic human tissues, and their role in the regulation of the immune response. Clin Exp Immunol 1992, 89(1):94-99.
124. Hishikawa T, Ogasawara H, Kaneko H, Shirasawa T, Matsuura Y, Sekigawa I, Takasaki Y, Hashimoto H, Hirose S, Handa S, Nagasawa R, Maruyama N Detection of antibodies to a recombinant gag protein derived from human endogenous retrovirus clone 4-1 in autoimmune diseases. Viral Immunol 1997, 10(3):137-147.
125. Sekigawa I, Kaneko H, Hishikawa T, Hashimoto H, Hirose S, Kaneko Y, Maruyama N HIV infection and SLE: their pathogenic relationship. Clin Exp Rheumatol 1998, 16(2):175-180.
126. Reichlin M Systemic lupus erythematosus. Antibodies to ribonuclear proteins. Rheum Dis Clin North Am 1994, 20(1):29-43.
127. Shefner R, Manheimer-Lory A, Davidson A, Paul E, Aranow C, Katz J, Diamond B Idiotypes in systemic lupus erythematosus. Clues for understanding etiology and pathogenicity. Chem Immunol 1990, 48:82-108.
128. Tan EM Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology. Adv Immunol 1989, 44:93-151.
129. Oldstone MB Molecular mimicry and autoimmune disease. Cell 1987, 50(6):819-820.
130. Perl A Mechanisms of viral pathogenesis in rheumatic disease. Ann Rheum Dis 1999, 58(8):454-461.
131. Perl A, Banki K Molecular mimicry, altered apoptosis, and immunomodulation as mechanisms of viral pathogenesis in systemic lupus erythematosus. Lupus: Molecular and Cellular Pathogenesis 1999, 43-64. Humana Press, Totowa, NJ. G.M. Kammer, G.C. Tsokos (Eds.).
132. Perl A, Rosenblatt JD, Chen IS, DiVincenzo JP, Bever R, Poiesz BJ, Abraham GN Detection and cloning of new HTLV-related endogenous sequences in man. Nucleic Acids Res 1989, 17(17):6841-6854.
133. Perl A, Isaacs CM, Eddy RL, Byers MG, Sait SN, Shows TB The human T-cell leukemia virus-related endogenous sequence (HRES1) is located on chromosome 1 at q42. Genomics 1991, 11(4):1172-1173.
134. Koopman WJ, Gay S The MRL-lpr/lpr mouse. A model for the study of rheumatoid arthritis. Scand J Rheumatol Suppl 1988, 75:284-289.
135. Tanaka A, O'Sullivan FX, Koopman WJ, Gay S Etiopathogenesis of rheumatoid arthritis-like disease in MRL/1 mice: II. Ultrastructural basis of joint destruction. J Rheumatol 1988, 15(1):10-16.
136. Brand A, Griffiths DJ, Herve C, Mallon E, Venables PJ Human retrovirus-5 in rheumatic disease. J Autoimmun 1999, 13(1):149-154.
137. Brookes SM, Pandolfino YA, Mitchell TJ, Venables PJ, Shattles WG, Clark DA, Entwistle A, Maini RN The immune response to and expression of cross-reactive retroviral gag sequences in autoimmune disease. Br J Rheumatol 1992, 31(11):735-742.
138. Dang H, Dauphinee MJ, Talal N, Garry RF, Seibold JR, Medsger TA, Alexander S, Feghali CA Serum antibody to retroviral gag proteins in systemic sclerosis. Arthritis Rheum 1991, 34(10):1336-1337.
139. Pani MA, Seidl C, Bieda K, Seissler J, Krause M, Seifried E, Usadel KH, Badenhoop K Preliminary evidence that an endogenous retroviral long-terminal repeat (LTR13) at the HLA-DQB1 gene locus confers susceptibility to Addison's disease. Clin Endocrinol (Oxf) 2002, 56(6):773-777.
140. Ranki A, Kurki P, Riepponen S, Stephansson E Antibodies to retroviral proteins in autoimmune connective tissue disease. Relation to clinical manifestations and ribonucleoprotein autoantibodies. Arthritis Rheum 1992, 35(12):1483-1491.
141. Kono DH, Burlingame RW, Owens DG, Kuramochi A, Balderas RS, Balomenos D, Theofilopoulos AN Lupus susceptibility loci in New Zealand mice. Proc Natl Acad Sci USA 1994, 91:10168-10172.
142. Drake CG, Rozzo SJ, Hirschfeld HF, Smarnworawong NP, Palmer E, Kotzin BL Analysis of the New Zealand Black contribution to lupus-like renal disease. Multiple genes that operate in a threshold manner. J Immunol 1995, 154(5):2441-2447.
143. Morel L, Rudofsky UH, Longmate JA, Schiffenbauer J, Wakeland EK Polygenic control of susceptibility to murine systemic lupus erythematosus. Immunity 1994, 1(3):219-229.
144. Morel L, Yu Y, Blenman KR, Caldwell RA, Wakeland EK Production of congenic mouse strains carrying genomic intervals containing SLE-susceptibility genes derived from the SLE-prone NZM2410 strain. Mamm Genome 1996, 7(5):335-339.
145. Brosius J Genomes were forged by massive bombardments with retroelements and retrosequences. Genetica 1999, 107(1-3):209-238.